Study evaluates effect of intrathecal fentanyl and hyperbaric bupivacaine co-administration in lower limb orthopedic surgeries
Hyperbaric bupivacaine is a popular choice for spinal anesthesia due to its ability to produce effective neural blockade and prolonged duration of action relative to other local anesthetics. Recent study compared the flow dynamics, block characteristics, and hemodynamic alterations between premixed intrathecal fentanyl and hyperbaric bupivacaine versus sequential administration of these drugs. It was a prospective, randomized, triple-blinded comparative study conducted among 160 patients undergoing lower limb orthopedic surgeries under spinal anesthesia.
Patients were randomly allocated into four groups:
Group A (control) received 15 mg hyperbaric bupivacaine and normal saline.
Group B received 15 mg hyperbaric bupivacaine premixed with 25 mcg fentanyl.
Group C received 25 mcg fentanyl followed by 15 mg hyperbaric bupivacaine.
Group D received 15 mg hyperbaric bupivacaine followed by 25 mcg fentanyl.
The onset and regression of sensory and motor blockade, hemodynamic parameters, time to first rescue analgesia, and adverse events were observed.
Study Results
The results showed that the onset of sensory and motor blockade was earliest in Group D, followed by Group C, Group B, and Group A. The duration of sensory and motor blockade was prolonged in Group D compared to the other groups. Patients in Group A experienced more hypotension than the other groups. The requirement of rescue analgesia was delayed in Groups C and D compared to the other groups.
Conclusion
The study concluded that administering 25 mcg fentanyl separately after 15 mg hyperbaric bupivacaine results in early onset and prolonged duration of sensory and motor blockade, intraoperative hemodynamic stability, delayed requirement of rescue analgesia postoperatively, and fewer side effects compared to its co-administration as a premixed solution or antecedent to hyperbaric bupivacaine. The authors propose that the differences are due to the effects of the order of drug administration on CSF dynamics and pharmacokinetics.
Here are the 3 key points from the research paper:
Key Points -
1. The study compared the flow dynamics, block characteristics, and hemodynamic alterations between premixed intrathecal fentanyl and hyperbaric bupivacaine versus sequential administration of these drugs in patients undergoing lower limb orthopedic surgeries under spinal anesthesia.
2. The results showed that administering 25 mcg fentanyl separately after 15 mg hyperbaric bupivacaine (Group D) resulted in the earliest onset and prolonged duration of sensory and motor blockade, intraoperative hemodynamic stability, delayed requirement of rescue analgesia postoperatively, and fewer side effects compared to its co-administration as a premixed solution (Group B) or administration of fentanyl before bupivacaine (Group C).
3. The authors propose that the differences in outcomes between the groups are due to the effects of the order of drug administration on CSF dynamics and pharmacokinetics.
Reference –
Saxena L, Bharadwaj A, Verma K, et al. (July 02, 2024) A Comparison of Subarachnoid Block Characteristics Following Co-administration of Fentanyl Premixed With Hyperbaric Bupivacaine Versus Antecedent or Succedent to Hyperbaric Bupivacaine: A Randomized Controlled Study. Cureus 16(7): e63666. DOI 10.7759/cureus.63666
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.